Erythropoietin in the critically ill - Is it more than just blood?

2Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Erythropoietin (EPO) has been in clinical use for the treatment of anemia for over 15 years. Recently it has been demonstrated that EPO has actions other than stimulating the bone marrow. It has been suggested that due to its tissue protecting effect, EPO may be effective in improving outcome in the critically ill. © 2004 BioMed Central Ltd.

Author supplied keywords

Cite

CITATION STYLE

APA

Corwin, H. L. (2004). Erythropoietin in the critically ill - Is it more than just blood? Critical Care, 8(5), 325–326. https://doi.org/10.1186/cc2949

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free